US 9422245
Neprilysin inhibitors
granted A61KA61K31/415A61K31/4155
Quick answer
US patent 9422245 (Neprilysin inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/415, A61K31/4155, A61K31/4178, A61K31/422